Sun Bio-Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-12-2024
- Paid Up Capital ₹ 1.00 M
as on 21-12-2024
- Company Age 19 Year, 23 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.50 M
as on 21-12-2024
- Revenue 0.81%
(FY 2016)
- Profit 279.73%
(FY 2016)
- Ebitda -186.41%
(FY 2016)
- Net Worth 1.69%
(FY 2016)
- Total Assets 12.96%
(FY 2016)
About Sun Bio-Formulations
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.50 M.
Nidaghatta Raju and Uma Udaykumar serve as directors at the Company.
- CIN/LLPIN
U24231KA2005PTC037832
- Company No.
037832
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2005
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sun Bio-Formulations Private Limited offer?
Sun Bio-Formulations Private Limited offers a wide range of products and services, including Cleaning Liquids & Wipes, Cleaning Chemicals, Kitchen Cleaners, Presentation Boards & Accessories, Black & White Board Accessories, FRP Lining, PU & Powder Coatings, Spray Paints, Welding Accessories, Nozzle Gel, Floor Broom.
Who are the key members and board of directors at Sun Bio-Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nidaghatta Raju  | Director | 02-Dec-2005 | Current |
| Uma Udaykumar | Director | 02-Dec-2005 | Current |
Financial Performance of Sun Bio-Formulations.
Sun Bio-Formulations Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 0.81% increase. The company also saw a substantial improvement in profitability, with a 279.73% increase in profit. The company's net worth moved up by a moderate rise of 1.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sun Bio-Formulations?
In 2017, Sun Bio-Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- AwakeS Research Incubation Skills And Entrepreneurship InstituteActive 10 years 6 months
Nidaghatta Raju is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 17 Apr 2006 | ₹2.50 M | Open |
How Many Employees Work at Sun Bio-Formulations?
Unlock and access historical data on people associated with Sun Bio-Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun Bio-Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Bio-Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
